Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells

Background: Compound A (CpdA) is a dissociating non-steroidal glucocorticoid receptor (GR) ligand which has anti-inflammatory properties exerted by down-modulating proinflammatory gene expression. By favouring GR monomer formation, CpdA does not enhance glucocorticoid (GC) response element-driven ge...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liberman, A.C., Antunica-Noguerol, M., Ferraz-de-Paula, V., Palermo-Neto, J., Castro, C.N., Druker, J., Holsboer, F., Perone, M.J., Gerlo, S., de Bosscher, K., Haegeman, G., Arzt, E.
Formato: Artículo publishedVersion
Publicado: 2012
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_19326203_v7_n4_p_Liberman
https://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=artiaex&d=paper_19326203_v7_n4_p_Liberman_oai
Aporte de:
id I28-R145-paper_19326203_v7_n4_p_Liberman_oai
record_format dspace
spelling I28-R145-paper_19326203_v7_n4_p_Liberman_oai2024-08-16 Liberman, A.C. Antunica-Noguerol, M. Ferraz-de-Paula, V. Palermo-Neto, J. Castro, C.N. Druker, J. Holsboer, F. Perone, M.J. Gerlo, S. de Bosscher, K. Haegeman, G. Arzt, E. 2012 Background: Compound A (CpdA) is a dissociating non-steroidal glucocorticoid receptor (GR) ligand which has anti-inflammatory properties exerted by down-modulating proinflammatory gene expression. By favouring GR monomer formation, CpdA does not enhance glucocorticoid (GC) response element-driven gene expression, resulting in a reduced side effect profile as compared to GCs. Considering the importance of Th1/Th2 balance in the final outcome of immune and inflammatory responses, we analyzed how selective GR modulation differentially regulates the activity of T-bet and GATA-3, master drivers of Th1 and Th2 differentiation, respectively. Results: Using Western analysis and reporter gene assays, we show in murine T cells that, similar to GCs, CpdA inhibits T-bet activity via a transrepressive mechanism. Different from GCs, CpdA induces GATA-3 activity by p38 MAPK-induction of GATA-3 phosphorylation and nuclear translocation. CpdA effects are reversed by the GR antagonist RU38486, proving the involvement of GR in these actions. ELISA assays demonstrate that modulation of T-bet and GATA-3 impacts on cytokine production shown by a decrease in IFN-γ and an increase in IL-5 production, respectively. Conclusions: Taken together, through their effect favoring Th2 over Th1 responses, particular dissociated GR ligands, for which CpdA represents a paradigm, hold potential for the application in Th1-mediated immune disorders. © 2012 Liberman et al. Fil:Liberman, A.C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Castro, C.N. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Druker, J. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. application/pdf http://hdl.handle.net/20.500.12110/paper_19326203_v7_n4_p_Liberman info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar PLoS ONE 2012;7(4) compound A dexamethasone gamma interferon glucocorticoid receptor interleukin 5 mifepristone transcription factor GATA 3 unclassified drug 2 (4 acetoxyphenyl) 2 chloro N methyl ethylammonium chloride 2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride aziridine derivative gamma interferon Gata3 protein, mouse glucocorticoid receptor mifepristone quaternary ammonium derivative T box transcription factor T box transcription factor TBX21 T-box transcription factor TBX21 transcription factor GATA 3 animal cell article cell differentiation controlled study cytokine production dimerization enzyme linked immunosorbent assay gene expression immune response immunocompetent cell ligand binding mouse nonhuman protein expression protein phosphorylation reporter gene spleen cell Th1 cell Th2 cell animal Bagg albino mouse biosynthesis drug antagonism drug effect drug potentiation immunology spleen T lymphocyte Th1 Th2 balance Murinae Animals Aziridines GATA3 Transcription Factor Interferon-gamma Mice Mice, Inbred BALB C Mifepristone Quaternary Ammonium Compounds Receptors, Glucocorticoid Spleen T-Box Domain Proteins T-Lymphocytes Th1 Cells Th1-Th2 Balance Th2 Cells Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells info:eu-repo/semantics/article info:ar-repo/semantics/artículo info:eu-repo/semantics/publishedVersion https://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=artiaex&d=paper_19326203_v7_n4_p_Liberman_oai
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-145
collection Repositorio Digital de la Universidad de Buenos Aires (UBA)
topic compound A
dexamethasone
gamma interferon
glucocorticoid receptor
interleukin 5
mifepristone
transcription factor GATA 3
unclassified drug
2 (4 acetoxyphenyl) 2 chloro N methyl ethylammonium chloride
2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride
aziridine derivative
gamma interferon
Gata3 protein, mouse
glucocorticoid receptor
mifepristone
quaternary ammonium derivative
T box transcription factor
T box transcription factor TBX21
T-box transcription factor TBX21
transcription factor GATA 3
animal cell
article
cell differentiation
controlled study
cytokine production
dimerization
enzyme linked immunosorbent assay
gene expression
immune response
immunocompetent cell
ligand binding
mouse
nonhuman
protein expression
protein phosphorylation
reporter gene
spleen cell
Th1 cell
Th2 cell
animal
Bagg albino mouse
biosynthesis
drug antagonism
drug effect
drug potentiation
immunology
spleen
T lymphocyte
Th1 Th2 balance
Murinae
Animals
Aziridines
GATA3 Transcription Factor
Interferon-gamma
Mice
Mice, Inbred BALB C
Mifepristone
Quaternary Ammonium Compounds
Receptors, Glucocorticoid
Spleen
T-Box Domain Proteins
T-Lymphocytes
Th1 Cells
Th1-Th2 Balance
Th2 Cells
spellingShingle compound A
dexamethasone
gamma interferon
glucocorticoid receptor
interleukin 5
mifepristone
transcription factor GATA 3
unclassified drug
2 (4 acetoxyphenyl) 2 chloro N methyl ethylammonium chloride
2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride
aziridine derivative
gamma interferon
Gata3 protein, mouse
glucocorticoid receptor
mifepristone
quaternary ammonium derivative
T box transcription factor
T box transcription factor TBX21
T-box transcription factor TBX21
transcription factor GATA 3
animal cell
article
cell differentiation
controlled study
cytokine production
dimerization
enzyme linked immunosorbent assay
gene expression
immune response
immunocompetent cell
ligand binding
mouse
nonhuman
protein expression
protein phosphorylation
reporter gene
spleen cell
Th1 cell
Th2 cell
animal
Bagg albino mouse
biosynthesis
drug antagonism
drug effect
drug potentiation
immunology
spleen
T lymphocyte
Th1 Th2 balance
Murinae
Animals
Aziridines
GATA3 Transcription Factor
Interferon-gamma
Mice
Mice, Inbred BALB C
Mifepristone
Quaternary Ammonium Compounds
Receptors, Glucocorticoid
Spleen
T-Box Domain Proteins
T-Lymphocytes
Th1 Cells
Th1-Th2 Balance
Th2 Cells
Liberman, A.C.
Antunica-Noguerol, M.
Ferraz-de-Paula, V.
Palermo-Neto, J.
Castro, C.N.
Druker, J.
Holsboer, F.
Perone, M.J.
Gerlo, S.
de Bosscher, K.
Haegeman, G.
Arzt, E.
Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
topic_facet compound A
dexamethasone
gamma interferon
glucocorticoid receptor
interleukin 5
mifepristone
transcription factor GATA 3
unclassified drug
2 (4 acetoxyphenyl) 2 chloro N methyl ethylammonium chloride
2-(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride
aziridine derivative
gamma interferon
Gata3 protein, mouse
glucocorticoid receptor
mifepristone
quaternary ammonium derivative
T box transcription factor
T box transcription factor TBX21
T-box transcription factor TBX21
transcription factor GATA 3
animal cell
article
cell differentiation
controlled study
cytokine production
dimerization
enzyme linked immunosorbent assay
gene expression
immune response
immunocompetent cell
ligand binding
mouse
nonhuman
protein expression
protein phosphorylation
reporter gene
spleen cell
Th1 cell
Th2 cell
animal
Bagg albino mouse
biosynthesis
drug antagonism
drug effect
drug potentiation
immunology
spleen
T lymphocyte
Th1 Th2 balance
Murinae
Animals
Aziridines
GATA3 Transcription Factor
Interferon-gamma
Mice
Mice, Inbred BALB C
Mifepristone
Quaternary Ammonium Compounds
Receptors, Glucocorticoid
Spleen
T-Box Domain Proteins
T-Lymphocytes
Th1 Cells
Th1-Th2 Balance
Th2 Cells
description Background: Compound A (CpdA) is a dissociating non-steroidal glucocorticoid receptor (GR) ligand which has anti-inflammatory properties exerted by down-modulating proinflammatory gene expression. By favouring GR monomer formation, CpdA does not enhance glucocorticoid (GC) response element-driven gene expression, resulting in a reduced side effect profile as compared to GCs. Considering the importance of Th1/Th2 balance in the final outcome of immune and inflammatory responses, we analyzed how selective GR modulation differentially regulates the activity of T-bet and GATA-3, master drivers of Th1 and Th2 differentiation, respectively. Results: Using Western analysis and reporter gene assays, we show in murine T cells that, similar to GCs, CpdA inhibits T-bet activity via a transrepressive mechanism. Different from GCs, CpdA induces GATA-3 activity by p38 MAPK-induction of GATA-3 phosphorylation and nuclear translocation. CpdA effects are reversed by the GR antagonist RU38486, proving the involvement of GR in these actions. ELISA assays demonstrate that modulation of T-bet and GATA-3 impacts on cytokine production shown by a decrease in IFN-γ and an increase in IL-5 production, respectively. Conclusions: Taken together, through their effect favoring Th2 over Th1 responses, particular dissociated GR ligands, for which CpdA represents a paradigm, hold potential for the application in Th1-mediated immune disorders. © 2012 Liberman et al.
format Artículo
Artículo
publishedVersion
author Liberman, A.C.
Antunica-Noguerol, M.
Ferraz-de-Paula, V.
Palermo-Neto, J.
Castro, C.N.
Druker, J.
Holsboer, F.
Perone, M.J.
Gerlo, S.
de Bosscher, K.
Haegeman, G.
Arzt, E.
author_facet Liberman, A.C.
Antunica-Noguerol, M.
Ferraz-de-Paula, V.
Palermo-Neto, J.
Castro, C.N.
Druker, J.
Holsboer, F.
Perone, M.J.
Gerlo, S.
de Bosscher, K.
Haegeman, G.
Arzt, E.
author_sort Liberman, A.C.
title Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
title_short Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
title_full Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
title_fullStr Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
title_full_unstemmed Compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
title_sort compound a, a dissociated glucocorticoid receptor modulator, inhibits t-bet (th1) and induces gata-3 (th2) activity in immune cells
publishDate 2012
url http://hdl.handle.net/20.500.12110/paper_19326203_v7_n4_p_Liberman
https://repositoriouba.sisbi.uba.ar/gsdl/cgi-bin/library.cgi?a=d&c=artiaex&d=paper_19326203_v7_n4_p_Liberman_oai
work_keys_str_mv AT libermanac compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT antunicanoguerolm compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT ferrazdepaulav compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT palermonetoj compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT castrocn compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT drukerj compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT holsboerf compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT peronemj compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT gerlos compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT debosscherk compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT haegemang compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
AT arzte compoundaadissociatedglucocorticoidreceptormodulatorinhibitstbetth1andinducesgata3th2activityinimmunecells
_version_ 1809356845841645568